Van beleggers
voor beleggers
desktop iconMarkt Monitor
  • Word abonnee
  • Inloggen

    Inloggen

    • Geen account? Registreren

    Wachtwoord vergeten?

Ontvang nu dagelijks onze kooptips!

word abonnee

Cancer Genetics Inc.

2 Posts
| Omlaag ↓
  1. ubu 1 december 2017 15:54
    www.technologyreview.com/s/607976/pro...

    "Promising New Cancer Drugs Won’t Go Far Unless Everyone Gets Genetic Testing"

    "To find patients, Loxo will need to convince more doctors to order comprehensive tests that screen multiple genes at once, including TRK. These advanced genetic tests, which can cost $5,000 or more, are offered by companies like Foundation Medicine, Caris Life Sciences, and Cancer Genetics. The problem is, insurers still consider the tests “experimental” and don’t routinely cover them, meaning patients are often stuck picking up the bill."

    Misschien toch nog even niet instappen.
2 Posts
|Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met je emailadres en wachtwoord.

Direct naar Forum

Indices

AEX 907,23 +0,33%
EUR/USD 1,0779 -0,02%
FTSE 100 8.381,35 0,00%
Germany40^ 18.766,00 +0,42%
Gold spot 2.369,44 +0,99%
NY-Nasdaq Composite 16.346,27 +0,27%

Stijgers

AALBER...
0,00%
ABN AM...
0,00%
Accsys
0,00%
ACOMO
0,00%
ADYEN NV
0,00%

Dalers

AALBER...
0,00%
ABN AM...
0,00%
Accsys
0,00%
ACOMO
0,00%
ADYEN NV
0,00%

Lees verder op het IEX netwerk Let op: Artikelen linken naar andere sites

Gesponsorde links